Raoul Jean-Luc, Raimbourg Judith, Hiret Sandrine, Adhoute Xavier, Senellart Hélène
Institut de cancérologie de l'Ouest, département d'oncologie médicale, site de Nantes, boulevard J.-Monod, 44805 Saint-Herblain cedex, France.
Institut de cancérologie de l'Ouest, département d'oncologie médicale, site de Nantes, boulevard J.-Monod, 44805 Saint-Herblain cedex, France.
Bull Cancer. 2018 May;105(5):502-507. doi: 10.1016/j.bulcan.2018.02.003. Epub 2018 Mar 19.
Hepatocellular carcinoma is the third most frequent cause of cancer death worldwide, particularly in Asia and Africa. Most cases complicate an underlying liver cirrhosis due to hepatitis B or C chronic virus infection or alcoholic abuse. But, following the current epidemics of obesity and type 2 diabetes, it appears that these diseases, associated in metabolic syndrome, are responsible for non alcoholic fatty liver disease at risk of HCC frequently before the stage of cirrhosis. Recent hypotheses consider that in the near future, cancer deaths due to HCC will overpass in USA those due to breast or colorectal cancers. Governments should develop policies to prevent obesity, type 2 diabetes and the metabolic syndrome as well as fight against alcoholism and hepatitis B and C virus infections.
肝细胞癌是全球第三大常见癌症死因,在亚洲和非洲尤为如此。大多数病例是由乙型或丙型慢性病毒感染或酒精滥用导致的潜在肝硬化所引发的并发症。但是,随着当前肥胖症和2型糖尿病的流行,似乎这些与代谢综合征相关的疾病,在肝硬化阶段之前,常常导致有患肝细胞癌风险的非酒精性脂肪性肝病。最近的假说认为,在不久的将来,美国因肝细胞癌导致的癌症死亡人数将超过因乳腺癌或结直肠癌导致的死亡人数。各国政府应制定政策来预防肥胖症、2型糖尿病和代谢综合征,以及与酗酒和乙型及丙型病毒感染作斗争。